Drug Target Review2023-12-08T16:00:00
Using saturation genome editing, researchers have created a map of disease-causing mutations for neurodevelopmental disorders and cancer.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-03T07:00:00Z
Contributor Marty Parrish and Steve Hoffmann, Drug Target Review
2026-09-01T07:00:00Z
Sponsored by Promega Corporation
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2025-05-14T14:30:00
Sponsored by Abzena
2023-05-30T13:51:56
Sponsored by BPS Bioscience
2025-05-08T09:00:00
Contributor Ning Ren
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-02-13T11:57:11
Sponsored by Agilent
Site powered by Webvision Cloud